Sequence Browser (P07949-1)

UniProt (Ref Seq)
Displayed Structure
Experimental Tertiary/Complex (PDB:XRay/EM)
Experimental Tertiary/Complex (PDB:NMR)
Modelled Tertiary (Phyre)
If the whole structure is coloured grey in '3D Structure Viewer' panel, please click the icon - on the top left corner of the viewer.
(If nothing changes then 'Sequence ↔ Structure' mapping may be unavailable).
1
1114
Isoform
Remark
Ref
P07949-1  
No experimental confirmation available.
VSP_040735
Click on Isoform of interest to be redirected to the corresponding page
Type
Variation
Position
splice variant
MSDPNWPGESPVPLTRADGTNTGFPRYPNDSVYANWMLSPSAAKLMDTFDS → RISHAFTRF
1064 - 1114
sequence variant
S → L
32
sequence variant
P → L
64
sequence variant
R → C
77
sequence variant
P → L
20
sequence variant
L → P
40
sequence variant
R → H
67
sequence variant
G → S
93
sequence variant
R → H
114
sequence variant
V → G
145
sequence variant
C → Y
157
sequence variant
F → S
174
sequence variant
R → P
180
sequence variant
R → C
114
sequence variant
C → S
142
sequence variant
P → L
155
sequence variant
R → Q
163
sequence variant
R → P
175
sequence variant
C → Y
197
sequence variant
R → H
231
sequence variant
T → A
278
sequence variant
T → P
278
sequence variant
V → M
292
sequence variant
R → Q
313
sequence variant
R → Q
330
sequence variant
D → Y
353
sequence variant
R → Q
360
sequence variant
V → A
376
sequence variant
N → H
394
sequence variant
V → M
397
sequence variant
V → M
412
sequence variant
A → E
432
sequence variant
E → K
480
sequence variant
C → CEEC
531
sequence variant
Missing
549 - 550
sequence variant
E → Q
595
sequence variant
C → G
609
sequence variant
C → W
609
sequence variant
C → G
611
sequence variant
C → S
611
sequence variant
C → Y
611
sequence variant
C → G
618
sequence variant
C → R
618
sequence variant
C → Y
618
sequence variant
C → G
620
sequence variant
C → S
620
sequence variant
C → Y
620
sequence variant
C → F
630
sequence variant
C → Y
630
sequence variant
ELC → DVR
632 - 634
sequence variant
C → CHELC
634
sequence variant
C → G
634
sequence variant
C → S
634
sequence variant
C → Y
634
sequence variant
A → G
639
sequence variant
A → G
641
sequence variant
S → P
690
sequence variant
R → Q
694
sequence variant
E → Q
762
sequence variant
S → R
767
sequence variant
V → I
778
sequence variant
L → F
790
sequence variant
V → L
804
sequence variant
R → Q
813
sequence variant
G → R
830
sequence variant
R → Q
873
sequence variant
S → A
891
sequence variant
G → S
894
sequence variant
K → E
907
sequence variant
M → T
918
sequence variant
S → F
922
sequence variant
T → M
946
sequence variant
R → G
972
sequence variant
M → T
980
sequence variant
P → L
1039
sequence variant
P → L
1049
sequence variant
Missing
1059
sequence variant
Y → C
1062
sequence variant
P → S
1067
mutagenesis site
D → N
707
mutagenesis site
K → R
758
sequence conflict
I → V
647
sequence conflict
A → G
750
sequence variant
P → T
198
sequence variant
E → K
251
sequence variant
T → N
278
sequence variant
R → Q
287
sequence variant
D → N
300
sequence variant
S → I
316
sequence variant
S → L
339
sequence variant
N → K
359
sequence variant
R → W
360
sequence variant
F → L
393
sequence variant
N → K
394
sequence variant
P → L
399
sequence variant
G → R
423
sequence variant
R → Q
475
sequence variant
D → N
489
sequence variant
G → E
593
sequence variant
R → Q
600
sequence variant
C → R
609
sequence variant
C → Y
609
sequence variant
C → R
611
sequence variant
C → W
611
sequence variant
C → F
618
sequence variant
C → S
618
sequence variant
C → F
620
sequence variant
C → R
620
sequence variant
C → W
620
sequence variant
Q → K
626
sequence variant
C → S
630
sequence variant
D → G
631
sequence variant
CR → WG
634 - 635
sequence variant
C → F
634
sequence variant
C → R
634
sequence variant
C → W
634
sequence variant
T → TCRT
636
sequence variant
A → G
640
sequence variant
P → L
679
sequence variant
G → S
691
sequence variant
R → T
749
sequence variant
S → P
765
sequence variant
E → D
768
sequence variant
N → S
783
sequence variant
Y → F
791
sequence variant
V → M
804
sequence variant
Y → S
826
sequence variant
R → L
844
sequence variant
A → F
883
sequence variant
F → L
893
sequence variant
R → Q
897
sequence variant
K → T
907
sequence variant
E → K
921
sequence variant
S → Y
922
sequence variant
F → L
961
sequence variant
P → L
973
sequence variant
R → C
982
sequence variant
P → Q
1039
sequence variant
L → V
1052
sequence variant
L → P
1061
sequence variant
M → T
1064
sequence variant
F → Y
1112
mutagenesis site
Missing
708 - 1114
mutagenesis site
Y → F
1062
sequence conflict
A → S
664
sequence conflict
S → P
904

To analyse the structural impact of your missense variant:

  • Select the corresponding experimental/modelled structure from the "Available Structures" Panel.
  • Right-click on the target structure and download it.
  • Go to our web server Missense3D to analyse structural impact.

  • Go to Missense3D
Protein:
Other Names:
Cadherin family member 12, Proto-oncogene c-Ret
Primary Accession:
Other Accessions:
A8K6Z2, Q15250, Q9BTB0, Q9H4A2
Gene :
RET*, synonyms (CDHF12, CDHR16, PTC, RET51)
Organism :
Human
Entry Name :
Length :
1,114
Mass (Da) :
124,319
Last modified :
01-Jan-1994
Version :
v3
Isoforms :
2 
Variants :
146 
Interactions :
4 
Structures :
Experimental 15 | Phyre prediction 4

Receptor tyrosine-protein kinase involved in numerous cellular mechanisms including cell proliferation, neuronal navigation, cell migration, and cell differentiation upon binding with glial cell derived neurotrophic factor family ligands. Phosphorylates PTK2/FAK1. Regulates both cell death/survival balance and positional information. Required for the molecular mechanisms orchestration during intestine organogenesis; involved in the development of enteric nervous system and renal organogenesis during embryonic life, and promotes the formation of Peyer's patch-like structures, a major component of the gut-associated lymphoid tissue. Modulates cell adhesion via its cleavage by caspase in sympathetic neurons and mediates cell migration in an integrin (e.g. ITGB1 and ITGB3)-dependent manner. Involved in the development of the neural crest. Active in the absence of ligand, triggering apoptosis through a mechanism that requires receptor intracellular caspase cleavage. Acts as a dependence receptor; in the presence of the ligand GDNF in somatotrophs (within pituitary), promotes survival and down regulates growth hormone (GH) production, but triggers apoptosis in absence of GDNF. Regulates nociceptor survival and size. Triggers the differentiation of rapidly adapting (RA) mechanoreceptors. Mediator of several diseases such as neuroendocrine cancers; these diseases are characterized by aberrant integrins-regulated cell migration. Mediates, through interaction with GDF15-receptor GFRAL, GDF15-induced cell-signaling in the brainstem which induces inhibition of food-intake. Activates MAPK- and AKT-signaling pathways (PubMed:28846097, PubMed:28953886, PubMed:28846099). Isoform 1 in complex with GFRAL induces higher activation of MAPK-signaling pathway than isoform 2 in complex with GFRAL (PubMed:28846099).

With
Entry
IntAct
Exp
PLCG1
P19174
EBI-2480756, EBI-79387
2
STAT3
P40763
EBI-2480756, EBI-518675
3
NOTCH2NL
Q7Z3S9
EBI-4423689, EBI-945833
3
Sh2b1
Q62985
EBI-2480756, EBI-7395583
3